Associations of Co-Occurring Substance Use Disorder With Diabetes Care Quality, Complications, and Hospitalizations

Datos Bibliográficos

ID9100522
AutoresMichele Knox (0000-0002-5234-8610, Division of Research, Kaiser Permanente Northern California Pleasanton, CA, autor de correspondencia), Dominic Hodgkin (0000-0002-4494-9176, The Heller School for Social Policy and Management, Brandeis University, Waltham, MA), Natalie E Slama (0000-0002-4930-1061, Division of Research, Kaiser Permanente Northern California Pleasanton, CA, autor de correspondencia), Stacy A Sterling (0000-0002-6987-8423, Kaiser Permanente, autor de correspondencia), Lisa K Gilliam (0000-0001-7054-1409, Endocrinology and Internal Medicine, Kaiser Permanente South San Francisco Medical Center, South San Francisco), Asma Asyyed (The Permanente Medical Group, Pleasanton), Esti Iturralde (0000-0001-6837-4998, Division of Research, Kaiser Permanente Northern California Pleasanton, CA, autor de correspondencia)
Año2025
Volumen63
Número6
Páginas443-448
Fecha de publicación2025-06-01
Peer ReviewedSí
Open AccessNo
TipoARTICLE
RevistaMedical Care (JOURNAL)
Identificadores de la revistaISSN: 0025-7079 • E-ISSN: 1537-1948
EditorialOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/mlr.0000000000002138
PMID40956599
OpenAlexW4409728401
IdiomaEN
Referencias citadas31

Background: Substance use disorder (SUD) is a risk factor for diabetes complications and hospitalizations, though a full continuum of diabetes care quality and health outcomes has not been examined among patients with diabetes accessing substance use treatment. Objective: To improve care delivery, this study compared patients with diabetes and co-occurring SUD to those with diabetes and no SUD. Population: In all, 4325 patients with diabetes and a SUD specialty treatment visit versus 255,652 patients with diabetes and no SUD diagnosis in a large, integrated delivery system from 2016 to 2021 were included. Research Design: Retrospective cohort study using electronic health record data. Modified Poisson regression models estimated relationships for co-occurring SUD and each outcome, adjusting for sociodemographic and clinical factors. Measures: Care quality measures included HbA1c, blood pressure, retinal and cholesterol screening, HbA1c < 8%, blood pressure < 140/90 mm Hg, and LDL-cholesterol < 100 mg/dL. Diabetes complications included cardiovascular, cerebrovascular, retinopathy, and lower limb conditions. Hospitalization types included diabetes-related and other conditions, for example, chronic liver disease, and psychiatric. Results: Patients with co-occurring SUD, compared with those without SUD, were more often male, younger, non-Hispanic White, and had a mood disorder. Co-occurring SUD was associated with more HbA1c screening and higher prevalence of HbA1c <8, yet also with elevated risks for nearly all complication types, and all but one hospitalization type, especially chronic liver disease and chronic pain-related hospitalization. Conclusions: Despite comparable or better diabetes care quality, elevated risk of complications and hospitalization persisted among patients with co-occurring SUD. Both biopsychosocial and system-based mechanisms likely contribute to these elevated risks. Silo-bridging care coordination may help address multifaceted health needs

Diabetes mellitus · MEDLINE · Psychiatry · Quality (philosophy) · Substance use · Chronic Disease Management Strategies · Diabetes Management and Education · Endocrinology · Medicine · Substance Abuse Treatment and Outcomes